Prognostic value of interim 18F-FDG PET/CT in adult follicular lymphoma treated with R-CHOP

被引:6
作者
Sun, Na [1 ]
Qiao, Wenli [1 ]
Xing, Yan [1 ]
Wang, Taisong [1 ]
Zhao, Jinhua [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Nucl Med, Sch Med, Shanghai 200080, Peoples R China
关键词
F-18-FDG; PET; CT; Follicular lymphoma; R-CHOP; B-CELL LYMPHOMA;
D O I
10.1007/s00277-023-05138-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeThe prognostic value of interim F-18-FDG PET/CT (I-PET) for follicular lymphoma (FL) is controversial, and may be related to the lack of strict standards in terms of age, chemotherapy regimen, and evaluation criteria in previous studies. This study aimed to investigate the prognostic value of I-PET in adult FL patients treated with R-CHOP.MethodsI-PET was performed in 30 adult FL patients after treatment with 3-5 cycles of R-CHOP. PET/CT images were assessed using the Deauville 5-point scale (D-5PS) criteria. Baseline PET/CT (B-PET) was performed in 24 of the patients with FL before treatment. The PET/CT image parameters, such as the SUVmax, TLG, and tMTV, were recorded. The prognostic values of sex, age, grade, Ann Arbor stage, LDH level, and I-PET were evaluated.ResultsKaplan-Meier analysis and Cox regression showed that sex, age, grade, Ann Arbor stage, LDH, and I-PET using the D-5PS criteria could not predict the PFS of adult patients with FL treated with R-CHOP (P>0.05). ROC curve analysis evaluated the predictive values of SUVmax, TLG, and tMTV in B-PET and I-PET and showed that none of them was predictive of PFS in adult FL patients (P>0.05). However, the variation in SUVmax ( increment SUVmax) was predictive of PFS in adult FL patients (AUC=0.83, P=0.040), and the cutoff threshold was 4.85.ConclusionsI-PET using the D-5PS criteria cannot predict the PFS of adult FL patients treated with R-CHOP. However, the increment SUVmax between B-PET and I-PET is applicable for the prognosis of adult patients with FL.
引用
收藏
页码:795 / 800
页数:6
相关论文
共 35 条
  • [1] Baseline 18F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy
    Aide, Nicolas
    Fruchart, Christophe
    Nganoa, Catherine
    Gac, Anne-Claire
    Lasnon, Charline
    [J]. EUROPEAN RADIOLOGY, 2020, 30 (08) : 4623 - 4632
  • [2] Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies
    Aldin, Angela
    Umlauff, Lisa
    Estcourt, Lise J.
    Collins, Gary
    Moons, Karel G. M.
    Engert, Andreas
    Kobe, Carsten
    von Tresckow, Bastian
    Haque, Madhuri
    Foroutan, Farid
    Kreuzberger, Nina
    Trivella, Marialena
    Skoetz, Nicole
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (01):
  • [3] Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study
    Bachy, Emmanuel
    Seymour, John F.
    Feugier, Pierre
    Offner, Fritz
    Lopez-Guillermo, Armando
    Belada, David
    Xerri, Luc
    Catalano, John V.
    Brice, Pauline
    Lemonnier, Francois
    Martin, Alejandro
    Casasnovas, Olivier
    Pedersen, Lars M.
    Dorvaux, Veronique
    Simpson, David
    Leppa, Sirpa
    Gabarre, Jean
    da Silva, Maria G.
    Glaisner, Sylvie
    Ysebaert, Loic
    Vekhoff, Anne
    Intragumtornchai, Tanin
    Le Gouill, Steven
    Lister, Andrew
    Estell, Jane A.
    Milone, Gustavo
    Sonet, Anne
    Farhi, Jonathan
    Zeuner, Harald
    Tilly, Herve
    Salles, Gilles
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (31) : 2815 - +
  • [4] The diagnostic and therapeutic challenges of Grade 3B follicular lymphoma
    Barraclough, Allison
    Bishton, Mark
    Cheah, Chan Y.
    Villa, Diego
    Hawkes, Eliza A.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (01) : 15 - 24
  • [5] FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
    Boellaard, Ronald
    O'Doherty, Mike J.
    Weber, Wolfgang A.
    Mottaghy, Felix M.
    Lonsdale, Markus N.
    Stroobants, Sigrid G.
    Oyen, Wim J. G.
    Kotzerke, Joerg
    Hoekstra, Otto S.
    Pruim, Jan
    Marsden, Paul K.
    Tatsch, Klaus
    Hoekstra, Corneline J.
    Visser, Eric P.
    Arends, Bertjan
    Verzijlbergen, Fred J.
    Zijlstra, Josee M.
    Comans, Emile F. I.
    Lammertsma, Adriaan A.
    Paans, Anne M.
    Willemsen, Antoon T.
    Beyer, Thomas
    Bockisch, Andreas
    Schaefer-Prokop, Cornelia
    Delbeke, Dominique
    Baum, Richard P.
    Chiti, Arturo
    Krause, Bernd J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (01) : 181 - 200
  • [6] Predictive Value of Interim and End-of-Therapy 18F-FDG PET/CT in Patients with Follicular Lymphoma
    Boo, Sun Ha
    Hyun, Joo O.
    Kwon, Soo Jin
    Yoo, Ie Ryung
    Kim, Sung Hoon
    Park, Gyeong Sin
    Choi, Byung Ock
    Jung, Seung Eun
    Cho, Seok-Goo
    [J]. NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 53 (04) : 263 - 269
  • [7] Follicular lymphoma
    Carbone, Antonino
    Roulland, Sandrine
    Gloghini, Annunziata
    Younes, Anas
    von Keude, Gottfried
    Lopez-Guillermo, Armando
    Fitzgibbons, Jude
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2019, 5 (1)
  • [8] Time for an individualized approach to first-line management of follicular lymphoma
    Cartron, Guillaume
    Trotman, Judith
    [J]. HAEMATOLOGICA, 2022, 107 (01) : 7 - 18
  • [9] Follicular lymphoma: is there an optimal way to define risk?
    Casulo, Carla
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2021, (01) : 313 - 319
  • [10] Epidemiology of Follicular Lymphoma
    Cerhan, James R.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2020, 34 (04) : 631 - +